Overview
Dr. Laura Rosenberger is an Associate Professor of Surgery, where she has a high-volume breast surgical oncology practice and enjoys all aspects of an academic career. She has clinical expertise and research interest in rare breast cancers, including sarcomas and a specific focus on phyllodes tumors. Dr. Rosenberger is the founding and coordinating Principal Investigator of multiple, multi-institutional studies, including a funded prospective germline testing study, and an actively accruing rare breast tumor registry with tissue biorepository. She has authored, or co-authored, over 75 peer-reviewed publications, and serves on multiple national committees including a member of the National Comprehensive Cancer Network, or NCCN, Breast Cancer Panel.
Current Appointments & Affiliations
Recent Publications
Standardized Pathologic Reporting for Phyllodes Tumors: Where are We after 3 Years?
Journal Article Ann Surg Oncol · February 2026 Full text Link to item CiteASO Visual Abstract: Contemporary Trends in Axillary Surgery for ER-Positive, HER2-Negative Breast Cancer Stratified by Neoadjuvant Endocrine Therapy, Neoadjuvant Chemotherapy, or Upfront Surgery.
Journal Article Ann Surg Oncol · February 2026 Full text Link to item CiteNeoadjuvant Endocrine Therapy Use in Estrogen Receptor Positive Breast Cancer: Insights from Practice Shifts During the COVID-19 Pandemic.
Journal Article Ann Surg Oncol · January 2026 BACKGROUND: The COVID-19 pandemic restricted operating room availability, prompting the Pandemic Breast Cancer Consortium to issue guidelines on deferring non-urgent surgical procedures. This led to an increased use of neoadjuvant endocrine therapy (NET) f ... Full text Link to item CiteRecent Grants
Defining Actionable Opportunities in Malignant Phyllodes via Genomic Profiling
ResearchPrincipal Investigator · Awarded by Food and Drug Administration · 2024 - 2027View All Grants